Non-Ablative Allo HSCT For Hematologic Malignancies or SAA
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery
- Status
- WITHDRAWN
- Phase
- PHASE1
Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders
- Status
- UNKNOWN
- Phase
- NA
Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
- Status
- UNKNOWN
- Phase
- NA
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
- Status
- TERMINATED
- Phase
- NA
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3